Max Levchin, Affirm founder and CEO, joins 'Mad Money' host Jim Cramer to talk quarterly results, consumer trends, growth ...

Pfizer and Bristol Myers Squibb are deeply out-of-favor drugmakers, but one could be the better turnaround candidate if you ...

Jim Cramer says he salutes CVS chief executive David Joyner. His remarks arrive after CVS raised its profit guidance for 2026 ...

Jim Cramer doesn't recommend Recursion Pharmaceuticals (NASDAQ: RXRX) due to weak earnings and CEO transition. Stock has ...

The investment case for pharmaceutical giant Pfizer is presenting a complex puzzle. Conflicting signals are creating a stark ...

Pfizer Inc. (NYSE:PFE) is one of the stocks Jim Cramer was recently asked about. During the episode, a caller inquired if the ...

CNBC commentator Jim Cramer predicted OpenAI‘s future in light of the recent advancements in AI technology. He posted, “It was only a matter of time before we heard from OpenAI about how it fell ...

Former hedge fund manager Jim Cramer shares his bullish view for Carvana stock. UBS also sees Carvana as true disruptor positioned to continue gaining market share. CVNA shares are already up roughly ...

The “Mad Money” host says investors are missing something big. Nvidia lost $200 billion in market cap amid investor fears. Jim Cramer drops a surpise verdict on Nvidia stock. Google and Meta challenge ...

Republican Sen. Jim Justice of West Virginia has agreed to pay nearly $5.2 million in overdue personal taxes, the latest saga for the former billionaire who has been followed by a trail of financial ...

'Mad Money' host Jim Cramer talks the current state of the AI trade. Supreme Court Deals Major Blow to Trump Removal Lane Kiffin talks regret, who told him to 'take the shot' before boarding private ...

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. Sen. Jim Justice, R-W.Va., listens as President ...